Jim Cramer: Buy Insys Therapeutics and International Paper, But Sell These 2 Stocks

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Jim Cramer made the following calls on September 27th, 2013. What do you think about his picks?

Insys Therapeutics Inc. (NASDAQ:INSY): Jim Cramer ranked this stock a Buy. The stock’s 52-week high is $37.94, and its 52-week low is $6.55. Cramer said that the stock is reasonably valued even though it has risen by over 300 percent this year, making Insys Therapeutics a reasonable call for someone looking to invest in a company that hasn’t been around for all that long. The company has posted especially strong gains in the past two months, a trend Cramer expects could continue into October as the stock builds momentum.

INSY 20130930

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business